Altaire Pharmaceuticals, Inc. - Feb. 11, 2022
Feb 11, 2022
Michael S. Sawaya
General Counsel & Vice President of Regulatory Affairs & Quality
311 West Ln.
P.O. Box 849
Sep 14, 2021 - Feb 11, 2022
Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not established and followed.Investigator(s): Bijoy Panicker, Jazmine N. Still, and Juanita P. Versace